Tag food and drug administration fda

Catheter Connections Receives 510k Clearance From FDA For DualCap Vascular Access Disinfecting Cap

Jul29

Catheter Connections, Inc., a manufacturer of innovative vascular access and infection control products, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its DualCap? product. DualCap is the only device that nests two disinfecting caps together – for both IV access points, the needleless injection site (NIS) [...]

Bionovo receives guidance to advance Menerba to Phase 3 Clinical Testing in Europe

Jul28

Pharmaceutical company Bionovo Inc (Nasdaq:BNVI) announced today the receipt of final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company’s lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe.This guidance reportedly defines the clinical and regulatory pathway to a European marketing authorisation for Menerba.The company plans [...]

Abbott awarded FDA approval for two new dosage strengths of SIMCOR for cholesterol

Jul28

Health care company Abbott (NYSE:ABT) stated on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR (niacin extended-release / simvastatin), a cholesterol medication.The company claimed the new SIMCOR dosage strengths combine 40 mg of simvastatin, which is the most commonly prescribed dose of simvastatin, [...]

Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe

Jul28

EMERYVILLE, Calif., July 29 /PRNewswire-FirstCall/ Bionovo, Inc. (Nasdaq: BNVI) announced today that it has received final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company's lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe. The guidance defines the clinical and regulatory pathway to a European [...]

Endologix Receives FDA Approval for PowerFit Aortic Extensions

Jul28

IRVINE, Calif., July 29 /PRNewswire-FirstCall/ Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its new PowerFit? Aortic Extensions. The PowerFit extensions are designed to provide physicians with enhanced visibility under fluoroscopy to facilitate precise device placement [...]

New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products

Jul27

A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories products are a large and growing segment of the medical device market, with some analysts estimating [...]

ACT Files Documentation With FDA for Clinical Trials Using ES Cells to Treat Eye Disease

Jul27

MARLBOROUGH, Mass.(BUSINESS WIRE) Advanced Cell Technology, Inc. (ACT?; OTCBB:ACTC) announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in [...]

The Washington Daybook

Jul27

TIME: 8 a.m.EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 35496) holds a meeting of the Cardiovascular and Renal Drugs Advisory Committee to discuss Revatio (sildenafil) for the treatment of pediatric pulmonary arterial hypertension (PAH) and whether to amend the clinical trials section of the written request, issued by [...]

Abbott’s SIMCOR ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths

Jul27

ABBOTT PARK, Ill., July 28 /PRNewswire-FirstCall/ Abbott (NYSE: ABT) today received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg [...]

FRC Action and Pro-Life Coalition Urge the FDA to Reject New Abortion-Causing Drug

Jul27

WASHINGTON, July 28 /PRNewswire-USNewswire/ Today FRC Action joined 19 pro-life groups in a letter sent to Food and Drug Administration (FDA) Commissioner Margaret Hamburg requesting that Ella, a drug under consideration for FDA approval that can cause abortions but is misleadingly labeled as an "emergency contraceptive," not be approved. Tom McClusky, FRC Action's Senior [...]

Your Ad Here